Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2011 - 2023)
Supernus Pharmaceuticals (SUPN) reported Interest Coverage Ratio of 19.33 for Q2 2023, down 408.31% year-over-year from 6.27 in Q2 2022, and down 661.94% quarter-over-quarter from 3.44 in Q1 2023.
Supernus Pharmaceuticals (SUPN) Interest Coverage Ratio (2011 - 2023) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 13 years of Interest Coverage Ratio data on file, last reported at 19.33 in Q2 2023.
- Interest Coverage Ratio for Q2 2023 came in at 19.33, down 408.31% year-over-year; the trailing twelve-month figure through Mar 2024 was 14.94 (down 300.91% YoY), and the FY2023 annual result was 2.18, down 133.44% from the prior year.
- Interest Coverage Ratio eased to 19.33 in Q2 2023 per SUPN's latest filing, from 3.44 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 21.54 in Q4 2022 and troughed at 19.33 in Q2 2023.
- A 5-year average of 4.58 and a median of 5.87 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio surged 1996.02% in 2022, then slumped 408.31% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 7.07 in 2019, then decreased by 0.17% to 7.05 in 2020, then sank by 85.43% to 1.03 in 2021, then surged by 1996.02% to 21.54 in 2022, then plunged by 189.73% to 19.33 in 2023.
- Business Quant data shows SUPN's Interest Coverage Ratio at 19.33 in Q2 2023, 3.44 in Q1 2023, and 21.54 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -19.33 |
| Mar 31, 2023 | 3.44 |
| Dec 31, 2022 | 21.54 |
| Sep 30, 2022 | -0.88 |
| Jun 30, 2022 | 6.27 |
| Mar 31, 2022 | 1.01 |
| Dec 31, 2021 | 1.03 |
| Sep 30, 2021 | 5.50 |
| Jun 30, 2021 | 6.24 |
| Mar 31, 2021 | 2.17 |
| Dec 31, 2020 | 7.05 |
| Sep 30, 2020 | 9.22 |
| Jun 30, 2020 | 7.83 |
| Mar 31, 2020 | 5.04 |
| Dec 31, 2019 | 7.07 |
| Sep 30, 2019 | 7.02 |
| Jun 30, 2019 | 7.90 |
| Mar 31, 2019 | 4.33 |
| Dec 31, 2018 | 4.58 |
| Sep 30, 2018 | 8.57 |